Sign inJoin waitlistJoin the waitlist

Syma Iqbal

Medical Director, Inpatient Services, Norris Cancer Hospital · University of Southern California/Los Angeles General Medical Center

Credentials: · · ·

History

Inpatient Services · University of Southern California/Los Angeles General Medical Center
Present
University of Southern California/Los Angeles General Medical Center
Present
University of Southern California/Los Angeles General Medical Center
Present

Medical Oncology
1998–2000
Internal Medicine
Cedars-Sinai Medical Center
1995–1998
Keck School of Medicine of USC
1991–1995

Research

FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent…
Journal of Clinical Oncology · 2007 · 384 citations
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
The Lancet Oncology · 2017 · 315 citations
A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels
Pharmacogenetics · 2004 · 250 citations

Heinz-Josef Lenz
39 papers
Anthony El-Khoueiry
15 papers
AS
Andy Sherrod
7 papers
CB
Charles Blanke
7 papers
Oliver Press
7 papers · 1 as a resident
Michael Gordon
5 papers
AB
Afsaneh Barzi
4 papers
Howard Hochster
4 papers
AG
Agustin Garcia
3 papers
Jaffer Ajani
3 papers
PG
Philip Gold
3 papers
Philip Philip
3 papers

Grants

University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)
National Cancer Institute · P30
Project lead · $1.3M · University of Southern California
1996–2026
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $181.6K · University of Southern California
2005–2009

Clinical trials

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
Principal investigator · Completed · Phase 2
University of Southern California
2016–2020
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Principal investigator · Completed · Phase 2
SWOG Cancer Research Network
2012–2019
A Pilot Study of PPX in Women With Metastatic Colorectal Cancer
Principal investigator · Completed · Phase 1
University of Southern California
2008–2011
FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer
Principal investigator · Terminated · Phase 2
University of Southern California
2006–2007